WEP CLINICAL ANNOUNCES RARE DISEASE DAY CAMPAIGN WEP Clinical, the specialist pharmaceutical services company, is proud to serve the rare disease community across the globe. As part of our overall mission to help patients [...]
WEP CLINICAL ANNOUNCES NEW UK WAREHOUSE FACILITIES WEP Clinical (WEP), the specialist pharmaceutical services company, is excited to announce that, from the 1st November 2018, it will be operating out of a larger warehousing [...]
WEP CLINICAL ANNOUNCES NEW US OFFICE FACILITIES WEP Clinical (WEP) is excited to announce that it is moving its US office location, due to a period of rapid growth and development for the company. [...]
WEP Clinical and MendeliKABS Inc. enter exclusive Named Patient distribution agreement for MDK-Nitisinone WEP Clinical, a global pharmaceutical and services company, and MendeliKABS Inc., a Canadian pharmaceutical company dedicated to the treatment of rare diseases, [...]
WE PHARMA ANNOUNCES NAME CHANGE TO WEP CLINICAL As of 25 November 2016, our company name will officially change from: WE Pharma to WEP Clinical We believe that our new name more accurately reflects [...]
